ALLOTT ANTHONY J

Director Allott sells 81,152 shares of SLGN for $4.5M at $55.22; holds 367,511 post-sale

Director Anthony J. Allott executed a discretionary open-market sale of 81,152 shares at $55.22 on May 16, 2025, reducing his holdings by 18.1% to 367,511 shares and generating $4,480,888.83 in proceeds. The transaction occurred near the 52-week high ($57.53), with the stock up 13.9% over the prior 30 days and up 2.6% over 90 days. Allott's prior trades at SLGN show mixed timing outcomes: his most recent SLGN sale on 2024-11-18 saw a 90-day decline of 0.4%, while two earlier 2023 sales preceded strong 90-day gains (5.4% and 9.2%), yielding a 33.3% well-timed rate at this ticker. His cross-ticker selling history shows an average 90-day return of 4.7% after his sales, reflecting a 33.33% well-timed rate—meaning his sell timing has been below average across all holdings. The company trades at a P/E of 20.80 with annual revenue declining 2.2% year-over-year against a $6.0B market cap, presenting a mature profile. This sale represents neither a liquidation nor a trivial position trim and merits routine investor attention given the substantial dollar amount and substantial percentage reduction, though the mixed prior timing record and moderate fundamentals context do not signal an urgent concern.

Director Allott sold 98,394 shares of SLGN at $53.91 for $5.3M; retains 456,812 shares. Stock -6.6% YoY revenue growth, P/E 19.60.

Anthony J Allott, a director of Silgan Holdings, sold 98,394 shares at $53.91 on 2024-11-18, reducing his position by 17.7% while retaining substantial ownership of 456,812 shares post-transaction. His cross-ticker track record shows 2 prior sells with an average 90-day well-timed rate of 0.00%, meaning neither prior sale preceded a subsequent decline, and his same-ticker history at SLGN (2 prior trades in 2023) also shows zero well-timed sells at the 90-day mark. The company faces headwinds with annual revenue growth of -6.6% year-over-year, though the current P/E of 19.60 and the director's continued substantial stake suggest he retains confidence despite the liquidation. The sale itself, executed at $53.91 versus a current price of $54.29, occurred near the stock's 52-week high of $55.13 and follows a 90-day gain of 7.2%, though without scheduled-transaction disclosure flags, the timing context cannot be fully determined.